Halogenated selective androgen receptor modulators and methods of use thereof

Details for Australian Patent Application No. 2007201969 (hide)

Owner University of Tennessee Research Foundation

Inventors Dalton, James T; Steiner, Mitchell S; Yin, Donghua; Miller, Duane D; He, Yali; Veverka, Karen A

Agent Griffith Hack

Pub. Number AU-B-2007201969

Parent 2003287074

Filing date 3 May 2007

Wipo publication date 24 May 2007

Acceptance publication date 24 June 2010

International Classifications

C07C 235/16 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/404 (2006.01)

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

C07C 235/24 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 255/60 (2006.01) Carboxylic acid nitriles

C07C 335/18 (2006.01) Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 271/12 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

17 May 2007 Complete Application Filed

24 May 2007 Application Open to Public Inspection

  Published as AU-B-2007201969

24 June 2010 Application Accepted

  Published as AU-B-2007201969

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201970-Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications

2007201968-Use of follistatin to increase muscle mass